KalVista Pharmaceuticals Inc. – Underwriting Agreements – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from 8-K 36 pages Securities Purchase Agreement

from 8-K 46 pages 5,500,000 Shares of Common Stock ($0.001 Par Value Per Share) KalVista Pharmaceuticals, Inc. Underwriting Agreement

from 8-K 58 pages 7,016,312 Shares of Common Stock Pre-Funded Warrants to Purchase Up to 3,483,688 Shares of Common Stock ($0.001 Par Value Per Share) KalVista Pharmaceuticals, Inc. Underwriting Agreement

from S-3 44 pages KalVista Pharmaceuticals, Inc. Shares of Common Stock (Par Value $0.001 Per Share) Controlled Equity Offeringsm Sales Agreement

from 8-K 44 pages 5,375,000 Shares KalVista Pharmaceuticals, Inc. Underwriting Agreement

from 8-K 44 pages KalVista Pharmaceuticals, Inc. Shares of Common Stock (Par Value $0.001 Per Share) Controlled Equity Offeringsm Sales Agreement

from 8-K 44 pages 4,000,000 KalVista Pharmaceuticals, Inc. Underwriting Agreement

from 8-K 47 pages KalVista Pharmaceuticals, Inc. Common Stock (Par Value $0.001 Per Share) At-The-Market Sales Agreement

from S-1/A 35 pages Carbylan Therapeutics, Inc. (A Delaware Corporation) [—] Shares of Common Stock Underwriting Agreement